EU exit spurs call for deal on radiotherapy

The UK will need new international agreements to keep its access to radiotherapy for cancer patients when the country withdraws from the EU’s Euratom nuclear watchdog. Britain imports all the radioactive medical isotopes used to treat many cancers and they are governed by strict international rules on the transportation of nuclear materials. Britain’s access to these isotopes is currently assured through its membership of Euratom, the European nuclear regulator, but the UK government confirmed last month that it would leave the organisation as part of its exit from the EU.
Financial Times